ConductScience.org, home

Paper29508136

A heterometallic ruthenium-gold complex displays antiproliferative, antimigratory, and antiangiogenic properties and inhibits metastasis and angiogenesis-associated proteases in renal cancer.

Elie BT and 3 others. J Biol Inorg Chem, 2018. Cited by 38 papers, by iCite.

Cite this record

ConductScience Library. A heterometallic ruthenium-gold complex displays antiproliferative, antimigratory, and antiangiogenic properties and inhibits metastasis and angiogenesis-associated proteases in renal cancer. Papers, record 29508136. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29508136

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A heterometallic ruthenium-gold complex displays antiproliferative, antimigratory, and antiangiogenic properties and inhibits metastasis and angiogenesis-associated proteases in renal cancer.
PubMed
Journal
J Biol Inorg Chem
PubMed
Year
2018
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
38
iCite
Relative citation ratio, by iCite
1.93
iCite
Revised in PubMed
2024-04-02
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Elie BTBenelita T
2Pechenyy YYuriy
3Uddin FFathema
4Contel MMaría

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, Renal CellMajor topic
Cell ProliferationMajor topic
Coordination ComplexesMajor topic
GoldMajor topic
Kidney NeoplasmsMajor topic
Neoplasm MetastasisMajor topic
Neovascularization, PathologicMajor topic
Protease InhibitorsMajor topic
Ruthenium CompoundsMajor topic
Cell Line, Tumor
Humans

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
SC1 CA182844NCI NIH HHSUnited StatesSC1CA182844PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References57

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119913918Cytotoxicity of half sandwich ruthenium(II) complexes with strong hydrogen bond acceptor ligands and their mechanism of action.J Inorg Biochem2010https://conductscience.org/library/papers/19913918PubMed
225435644Organometallic Titanocene-Gold Compounds as Potential Chemotherapeutics in Renal Cancer. Study of their Protein Kinase Inhibitory Properties.Organometallics2014https://conductscience.org/library/papers/25435644PubMed
327467926Cytokine patterns in cancer patients: A review of the correlation between interleukin 6 and prognosis.Oncoimmunology2016https://conductscience.org/library/papers/27467926PubMed
425383481Auranofin, an anti-rheumatic gold compound, modulates apoptosis by elevating the intracellular calcium concentration ([ca2+]I) in mcf-7 breast cancer cells.Cancers (Basel)2014https://conductscience.org/library/papers/25383481PubMed
525367033Pericellular proteolysis in cancer.Genes Dev2014https://conductscience.org/library/papers/25367033PubMed
614661062Resveratrol inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting JNK and PKC delta signal transduction.Oncogene2004https://conductscience.org/library/papers/14661062PubMed
726597527Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response.Nat Rev Cancer2015https://conductscience.org/library/papers/26597527PubMed
817320769Inhibition of thioredoxin reductase by auranofin induces apoptosis in cisplatin-resistant human ovarian cancer cells.Free Radic Biol Med2007https://conductscience.org/library/papers/17320769PubMed
920542334The gold compound auranofin induces apoptosis of human multiple myeloma cells through both down-regulation of STAT3 and inhibition of NF-κB activity.Leuk Res2011https://conductscience.org/library/papers/20542334PubMed
1027717148A Macrocyclic Ruthenium(III) Complex Inhibits Angiogenesis with Down-Regulation of Vascular Endothelial Growth Factor Receptor-2 and Suppresses Tumor Growth In Vivo.Angew Chem Int Ed Engl2016https://conductscience.org/library/papers/27717148PubMed
1110620700The role of p38 mitogen-activated protein kinase in IL-6 and IL-8 production from the TNF-alpha- or IL-1beta-stimulated rheumatoid synovial fibroblasts.FEBS Lett2000https://conductscience.org/library/papers/10620700PubMed
1214647459Induction of G0/G1 cell cycle arrest in ovarian carcinoma cells by the anti-inflammatory drug NS-398, but not by COX-2-specific RNA interference.Oncogene2003https://conductscience.org/library/papers/14647459PubMed
1325253202A TrxR inhibiting gold(I) NHC complex induces apoptosis through ASK1-p38-MAPK signaling in pancreatic cancer cells.Mol Cancer2014https://conductscience.org/library/papers/25253202PubMed
1428142080New copper(I) and heteronuclear copper(I)-ruthenium(II) complexes: Synthesis, structural characterization and cytotoxicity.J Inorg Biochem2017https://conductscience.org/library/papers/28142080PubMed
1523786413Potential anticancer heterometallic Fe-Au and Fe-Pd agents: initial mechanistic insights.J Med Chem2013https://conductscience.org/library/papers/23786413PubMed
1628951461Inflammatory Monocytes Promote Perineural Invasion via CCL2-Mediated Recruitment and Cathepsin B Expression.Cancer Res2017https://conductscience.org/library/papers/28951461PubMed
1721958150Titanocene-phosphine derivatives as precursors to cytotoxic heterometallic TiAu2 and TiM (M = Pd, Pt) compounds. Studies of their interactions with DNA.Inorg Chem2011https://conductscience.org/library/papers/21958150PubMed
1824637564Ligand substitutions between ruthenium-cymene compounds can control protein versus DNA targeting and anticancer activity.Nat Commun2014https://conductscience.org/library/papers/24637564PubMed
1921516419Cell migration and invasion assays.Methods Mol Biol2011https://conductscience.org/library/papers/21516419PubMed
2016264276Up-regulation of defense enzymes is responsible for low reactive oxygen species in malignant prostate cancer cells.Exp Mol Med2005https://conductscience.org/library/papers/16264276PubMed

See all 57 referencesDownload CSV of references

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 38 citations.

PMIDTitleJournalYearIn PapersSource
42193354Heterometallic Multinuclear Ruthenium Complexes as Cytotoxic Agents.Biomedicines2026https://conductscience.org/library/papers/42193354PubMed
41494918High Cytotoxicity of Ruthenium(II) and Gold(I) Bimetallic Complexes and Its Precursors.Inorg Chem2026https://conductscience.org/library/papers/41494918PubMed
41304972Review of the Most Important Research Trends in Potential Chemotherapeutics Based on Coordination Compounds of Ruthenium, Rhodium and Iridium.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/41304972PubMed
39200227Heteronuclear Complexes with Promising Anticancer Activity against Colon Cancer.Biomedicines2024https://conductscience.org/library/papers/39200227PubMed
38256884A Ru(II)-Strained Complex with 2,9-Diphenyl-1,10-phenanthroline Ligand Induces Selective Photoactivatable Chemotherapeutic Activity on Human Alveolar Carcinoma Cells via Apoptosis.Pharmaceuticals (Basel)2023https://conductscience.org/library/papers/38256884PubMed
37727388Metallodrugs in the battle against non-small cell lung cancer: unlocking the potential for improved therapeutic outcomes.Front Pharmacol2023https://conductscience.org/library/papers/37727388PubMed
37507346Platinum(IV)-Gold(I) Agents with Promising Anticancer Activity: Selected Studies in 2D and 3D Triple-Negative Breast Cancer Models.Chemistry2023https://conductscience.org/library/papers/37507346PubMed
37332817
Homobimetallic Au(I)-Au(I) and Heterotrimetallic Au(I)-Fe(II)-Au(I) Complexes with Dialkyldithiophosphates and Phosphine Ligands: Structural Characterization, DFT Analysis, and Tyrosinase Inhibitory and Biological Effects.
ACS Omega2023https://conductscience.org/library/papers/37332817PubMed
371913195-Nitrofuryl-Containing Thiosemicarbazone Gold(I) Compounds: Synthesis, Stability Studies, and Anticancer Activity.Chempluschem2023https://conductscience.org/library/papers/37191319PubMed
37071737Next Generation Gold Drugs and Probes: Chemistry and Biomedical Applications.Chem Rev2023https://conductscience.org/library/papers/37071737PubMed
36615466Highlights of New Strategies to Increase the Efficacy of Transition Metal Complexes for Cancer Treatments.Molecules2022https://conductscience.org/library/papers/36615466PubMed
36566618Promising heterometallic compounds as anticancer agents: Recent studies in vivo.Curr Opin Chem Biol2023https://conductscience.org/library/papers/36566618PubMed
35224494Ruthenium(ii)-arene complexes as anti-metastatic agents, and related techniques.RSC Med Chem2022https://conductscience.org/library/papers/35224494PubMed
35170871Metallodrugs: an approach against invasion and metastasis in cancer treatment.FEBS Open Bio2022https://conductscience.org/library/papers/35170871PubMed
34588987Gold Compounds and the Anticancer Immune Response.Front Pharmacol2021https://conductscience.org/library/papers/34588987PubMed
32832867Auranofin-Based Analogues Are Effective Against Clear Cell Renal Carcinoma In Vivo and Display No Significant Systemic Toxicity.ACS Pharmacol Transl Sci2020https://conductscience.org/library/papers/32832867PubMed
32695747Recent Advances of Gold Compounds in Anticancer Immunity.Front Chem2020https://conductscience.org/library/papers/32695747PubMed
32455715Cysteine Cathepsins Inhibition Affects Their Expression and Human Renal Cancer Cell Phenotype.Cancers (Basel)2020https://conductscience.org/library/papers/32455715PubMed
32305711SEC hyphenated to a multielement-specific detector unravels the degradation pathway of a bimetallic anticancer complex in human plasma.J Chromatogr B Analyt Technol Biomed Life Sci2020https://conductscience.org/library/papers/32305711PubMed
31192543Preclinical evaluation of an unconventional ruthenium-gold-based chemotherapeutic: RANCE-1, in clear cell renal cell carcinoma.Cancer Med2019https://conductscience.org/library/papers/31192543PubMed

See all 21 cited byDownload CSV of cited by

Genes25

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ADAM8101PubTator's text mininghttps://conductscience.org/library/genes/101NCBI Gene
ADAM98754PubTator's text mininghttps://conductscience.org/library/genes/8754NCBI Gene
ANXA5308PubTator's text mininghttps://conductscience.org/library/genes/308NCBI Gene
CTSB1508PubTator's text mininghttps://conductscience.org/library/genes/1508NCBI Gene
CTSD1509PubTator's text mininghttps://conductscience.org/library/genes/1509NCBI Gene
CTSL1514PubTator's text mininghttps://conductscience.org/library/genes/1514NCBI Gene
CTSS1520PubTator's text mininghttps://conductscience.org/library/genes/1520NCBI Gene
CTSZ1522PubTator's text mininghttps://conductscience.org/library/genes/1522NCBI Gene
CXCL83576PubTator's text mininghttps://conductscience.org/library/genes/3576NCBI Gene
EREG2069PubTator's text mininghttps://conductscience.org/library/genes/2069NCBI Gene
IL12B3593PubTator's text mininghttps://conductscience.org/library/genes/3593NCBI Gene
IL133596PubTator's text mininghttps://conductscience.org/library/genes/3596NCBI Gene
IL17A3605PubTator's text mininghttps://conductscience.org/library/genes/3605NCBI Gene
IL53567PubTator's text mininghttps://conductscience.org/library/genes/3567NCBI Gene
IL63569PubTator's text mininghttps://conductscience.org/library/genes/3569NCBI Gene
MMP14312PubTator's text mininghttps://conductscience.org/library/genes/4312NCBI Gene
MMP104319PubTator's text mininghttps://conductscience.org/library/genes/4319NCBI Gene
MMP124321PubTator's text mininghttps://conductscience.org/library/genes/4321NCBI Gene
MMP134322PubTator's text mininghttps://conductscience.org/library/genes/4322NCBI Gene
MMP34314PubTator's text mininghttps://conductscience.org/library/genes/4314NCBI Gene

See all 25 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29508136

GET https://conductscience.org/api/papers/v1/29508136/references?page=2